Evidence map›Paper›PMID 38947519›Full record

ArticleiScience2024

CT135 mediates the resistance of

Mark C Fernandez, Yvonne Cosgrove Sweeney, Robert J Suchland, Steven J Carrell, Olusegun O Soge, Isabelle Q Phan, Daniel D Rockey, Dorothy L Patton, Kevin Hybiske

Abstract read
In one paragraph

Article in iScience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. RNF213-dependent lytic destruction ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Genome-wide association studies ofInfection and immunity · 2026
    Article
  3. Inclusion Membrane Proteins ofMicroorganisms · 2026
    Review
  4. TheeLife · 2025
    Article
  5. Complete deletion of theInfection and immunity · 2025
    Article
  6. ThebioRxiv : the preprint server for biology · 2025
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mark C FernandezDepartment of Global Health, University of Washington, Seattle, WA 98109, USA.
Yvonne Cosgrove SweeneyDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA 98109, USA.
Robert J SuchlandDepartment of Medicine, University of Washington, Seattle, WA 98109, USA.
Steven J CarrellDepartment of Biomedical Sciences, Oregon State University, Corvallis, OR 97331, USA.
Olusegun O SogeDepartment of Global Health, University of Washington, Seattle, WA 98109, USA.
Isabelle Q PhanSeattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109, USA.
Daniel D RockeyDepartment of Biomedical Sciences, Oregon State University, Corvallis, OR 97331, USA.
Dorothy L PattonDepartment of Obstetrics and Gynecology, University of Washington, Seattle, WA 98109, USA.
Kevin HybiskeCenter for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109, USA.

Funding

Washington National Primate Research CenterP51OD010425 · OD · UNIVERSITY OF WASHINGTON · PI Mari Ostendorf · 2012 to 2026
$201.8M
WaNPRC Macaca nemestrina SPF Breeding ColonyU42OD011123 · OD · UNIVERSITY OF WASHINGTON · PI CHARLOTTE HOTCHKISS · 2012 to 2026
$34.4M
Functional genomics for ChlamydiaR01AI126785 · NIAID · UNIVERSITY OF WASHINGTON · PI HEFTY, P SCOTT, HYBISKE, KEVIN · 2016 to 2025
$7.1M
NIAID NIH HHS R01 AI126785NIH HHS P51 OD010425NIH HHS U42 OD011123
6 · The paper itself

Abstract

Evading host innate immune defenses is a critical feature of

Indexed as

immunologyMicrobiologyMycology

Identifiers

PMID38947519
PMCPMC11214326

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.